Condition: Covid19 · Olfactory Dysfunction · Sponsor: Universitaire Ziekenhuizen KU Leuven
Investigation of the mechanisms of persistent SARS-CoV-2 associated olfactory dysfunction (OD) in patients with well-documented olfactory function. The investigators plan to collect olfactory cleft biopsies and cytobrushes in COVID-19 patients and controls.
This description comes directly from the study's public registry record.
Laura van Gerven · +3216336342 · laura.vangerven@uzleuven.be
Sabrina Bischoff · +41763655671 · sabrina.bischoff@uzleuven.be
Always discuss trial participation with your own doctor first.
| Cliniques Universitaires Saint-Luc | Brussels, Brussels Capital, Belgium | Recruiting |
| UZ/KU Leuven | Leuven, Vlaams-Brabant, Belgium | Recruiting |
| AZ Sint-Jan Brugge | Bruges, West-Vlaanderen, Belgium | Recruiting |
| University Hospital Carl Gustav Carus | Dresden, Dresden, Germany | Recruiting |
| Max Planck Research Unit for Neurogenetics | Frankfurt am Main, Frankfurt, Germany | Active Not Recruiting |
| Hôpitaux Universitaires de Genève | Geneva, Canton of Geneva, Switzerland | Recruiting |
| University of Zurich and University Hospital Zurich | Zurich, Canton of Zurich, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06482138